Stem Cell Research & TherapyCell BiologyPeer-reviewed journal article
Interactions among Merlin, Arkadia, and SKOR2 mediate NF2-associated Schwann cell proliferation in human.
Pei-Ciao TangiD, Se Young UmiD, Anderson B. MayfieldiD, Olena R. BrachoiD, Christian Del Castillo, Christine Thuyvan DinhiD, Derek M. DykxhoorniD, Xue Zhong LiuiD
Abstract
NF2-Related Schwannomatosis (previously referred to as Neurofibromatosis Type 2, or NF2) is a genetic-associated disease resulting from mutations in the gene, NF2. NF2 encodes the merlin protein, which acts as a tumor suppressor. Bilateral vestibular schwannoma (VS) is a hallmark of NF2. Although the exactly molecular mechanism mediating NF2-driven schwannomatosis remain unclear, it is known that defective Merlin protein functionality leads to abnormal cell proliferation. Herein, we utilized a human induced pluripotent stem cell (hiPSC)-based Schwann cell (SC) model to investigate the role of merlin in human SCs. SCs were derived from hiPSCs carrying a NF2 mutation (c.191 T > C; p. L64P), its isogenic wild-type control cell line, and a NF2 patient-derived hiPSC line. NF2 mutant SCs showed abnormal cellular morphology and proliferation. Proteomic analyses identified novel interaction partners for Merlin - Arkadia and SKOR2. Our results established a new model in which merlin interacts with Arkadia and SKOR2 and this interaction is required for the proper activation of the SMAD-dependent pathway in TGF{beta} signaling.
- organism: human
- assay: proteomics
- research focus: cell type annotation
- research focus: cell signaling & trafficking
- research focus: differential expression
- approach: experimental assay
- Citations
- 2
- FWCI
- 1.12
- Field percentile
- top 26%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- MERLIN-DEFICIENT iPSCs AS AN IN VITRO MODEL SYSTEM FOR STUDIYNG NF2 PATHOGENESIS
N. Catasus, M. Torres-Martin, … E. CASTELLANOS·bioRxiv·Dec 14, 2022
- Cellular mechanisms of heterogeneity in NF2-mutant schwannoma
C. C. MacKenzie, J. Vitte, … A. I. McClatchey·bioRxiv·Dec 31, 2020
- Merlin restoration prevents schwannoma progression in a genetically engineered mouse model of NF2-SWN
Jérémie Vitte, Christine Chiasson-MacKenzie, … Marco Giovannini·bioRxiv·Sep 16, 2026
- NF2 lacking exon 11 isoform induced by antisense gene therapy is able to recover partially merlin deficiency on NF2-related Schwannomatosis iPSC-derived spheroid model
Gemma Casals-Sendra, Ignasi Jarne-Sanz, … Elisabeth Castellanos·Molecular Therapy — Nucleic AcidsPeer-reviewed·Aug 3, 2026
- Variable Schwann cell merlin inactivation is targetable with TEAD1 inhibition in schwannomas.
Maxwell Thomas Laws, Dhruval Bhatt, … Prashant Chittiboina·bioRxiv·Nov 15, 2025
- A novel induced pluripotent stem cell model of schwann cell differentiation reveals NF2-related gene regulatory networks of the extracellular matrix
Olivia Lazaro, Sihong Li, … Steven D. Rhodes·bioRxiv·May 2, 2024